Healthtech Startups

0 investors

0 investors

Vital Data Technology develops the Affinitē platform, which provides real-time, data-driven insights to align health plan payers, providers, and members. The software aims to improve care quality and lower costs across the healthcare ecosystem.

0 investors

Vitalchat is an open, hardware-agnostic virtual care platform that unifies clinical and support teams in a single interface and integrates with telemetry, ambient monitoring, and clinical workflow tools. It supports care across settings from emergency and acute care to home, and is built for health systems including those serving rural healthcare.

0 investors

0 investors

0 investors

VitaPixel develops the SLC, a universal hardware upgrade for existing ophthalmology slit lamps that captures the clinician's view with high-dynamic-range digital cameras and streams it live to XR glasses in stereoscopic 3D. It is aimed at ophthalmologists, letting them examine patients in an upright posture to reduce the neck and back strain associated with traditional eyepieces.

0 investors

Vitro Biopharma is a biotechnology company developing Wharton's jelly-derived (umbilical cord) mesenchymal stem cell therapies for autoimmune diseases and inflammatory disorders. It manufactures its cell therapy product candidates under cGMP conditions with ISO 9001:2015 and ISO 13485:2016 certification for the immunology and inflammation market.

0 investors

Vitruvias Therapeutics was a pharmaceutical company; it has ceased operations, and its products are now owned and/or distributed by H2-Pharma LLC.

0 investors

0 investors

0 investors

Vivamed develops a minimally invasive neuromodulation treatment for obstructive sleep apnea. The company operates in the medical device and sleep health space.

0 investors

0 investors

0 investors

Vivos Inc. is a medical device company developing Precision Radionuclide Therapy (PRnT), a treatment that delivers targeted radiation directly into cancerous tumors via an injectable radionuclide device. Its technology is applied to cancer treatment in humans (RadioGel) and animals (IsoPet), operating in the precision oncology and radionuclide therapy space.

0 investors

0 investors

Volition develops Nu.Q epigenetics-based blood tests that detect nucleosome changes associated with cancer, sepsis, and other diseases in both humans and animals. Its products include diagnostic assays for NETosis detection, research-use assays, and a canine cancer blood test.

0 investors

0 investors

Voom is a medical device company that develops products for minimally invasive foot and ankle surgeries, with a focus on bunion procedures performed by surgeons. The company emphasizes patient-centered care and surgical innovation through specialized technology and surgeon training.

0 investors

0 investors

0 investors

Voximetry conducts PHS-funded research activities, including basic and applied research and product development related to public health. This page is the company's financial conflict of interest (FCOI) policy rather than a product description.

0 investors

Voyager Biomedical develops VenaSure, an implanted porous titanium device that creates a palpable access window to guide reliable cannulation of AV fistulas for hemodialysis patients. The device is intended for use in dialysis centers and home dialysis to reduce needle-related vein damage during vascular access.

0 investors

0 investors